BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28288046)

  • 1. FDG PET/CT in Pediatric Neurolymphomatosis.
    de Vaugelade C; de Clermont-Gallerande H; Meyer M; My Duyen Tiphaine A; Benjamin A; Ducassou S; Chateil JF; Fernandez P
    Clin Nucl Med; 2017 May; 42(5):e255-e257. PubMed ID: 28288046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma.
    Bund C; Heimburger C; Trensz P; Fohrer C; Kremer S; Namer IJ
    Clin Nucl Med; 2017 Jun; 42(6):458-460. PubMed ID: 28240665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorothymidine PET/CT in neurolymphomatosis.
    Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
    Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
    Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
    Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurolymphomatosis: MRI and (18) FDG-PET features.
    Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and 18F-FDG-PET/CT in a rare case of early (precursor) B-lymphoblastic leukaemia with bone involvement as initial manifestation.
    Cistaro A; La Delfa V; Di Rosa G; Cogoni M; Quartuccio N
    Nucl Med Rev Cent East Eur; 2017; 20(1):57-59. PubMed ID: 28218349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Common Iliac Artery Angiosarcoma With Multiple Bone Metastases Revealed by Dual-Time Point FDG PET/CT Imaging.
    Wang R; Wang X; Ji B; Guan Q; Chen B
    Clin Nucl Med; 2019 Mar; 44(3):232-233. PubMed ID: 30624266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
    Ganeshalingam R; Roach P; Schembri GP
    Clin Nucl Med; 2019 Feb; 44(2):145-147. PubMed ID: 30516683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
    Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
    Patel D; Anderson TM; Lu Y
    Clin Nucl Med; 2016 Sep; 41(9):710-1. PubMed ID: 27187733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
    Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurolymphomatosis; a case report.
    Aboueldahab N; Shafik MA; Megahed A; Vesselle H
    Clin Imaging; 2021 Dec; 80():329-333. PubMed ID: 34488168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Unique Case of Erdheim-Chester Disease With Cervical and Lumbosacral Nerve Involvement: FDG PET/CT Finding.
    Niu N; Cao X; Cui R
    Clin Nucl Med; 2016 Nov; 41(11):881-883. PubMed ID: 27607166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer bone metastases together with osteopoikilosis diagnosed using bone scintigraphy and
    Prado Wohlwend S; Sánchez Vaño R; Sopena Novales P; Uruburu García E; Aparisi Rodríguez F; Martínez Carsí C
    Rev Esp Med Nucl Imagen Mol; 2017; 36(3):189-193. PubMed ID: 27329562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.